MICHAEL WHITE: Open Payments
NPI 1780673707 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,270 in 20 payments from 10 companies in 2025. Trend: 2023 $715 · 2024 $1,282 · 2025 $1,270
Food & beverage: $1,270
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 5 | $322 |
| Tandem Diabetes Care, Inc. | 2 | $244 |
| Enterra Medical, Inc. | 1 | $156 |
| Corcept Therapeutics | 4 | $146 |
| Ascendis Pharma Endocrinology Inc | 2 | $134 |
| Dexcom, Inc. | 1 | $129 |
| Sequel Med Tech, LLC | 1 | $46 |
| Abbott Laboratories | 2 | $45 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
Products named: MINIMED 780G, t:slim X2 Insulin Pump with Control-IQ, Korlym, Yorvipath, Dexcom G6 Transmitter, TWIIST, FREESTYLE LIBRE 3, ISTURISA.
Industry payments across ID — which companies pay providers there.
